Christoph Kapitza

4.2k total citations
76 papers, 3.2k citations indexed

About

Christoph Kapitza is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Christoph Kapitza has authored 76 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Endocrinology, Diabetes and Metabolism, 28 papers in Surgery and 22 papers in Molecular Biology. Recurrent topics in Christoph Kapitza's work include Diabetes Management and Research (49 papers), Diabetes Treatment and Management (46 papers) and Pancreatic function and diabetes (27 papers). Christoph Kapitza is often cited by papers focused on Diabetes Management and Research (49 papers), Diabetes Treatment and Management (46 papers) and Pancreatic function and diabetes (27 papers). Christoph Kapitza collaborates with scholars based in Germany, United States and Denmark. Christoph Kapitza's co-authors include Tim Heise, Leszek Nosek, Lutz Heinemann, Anne Flint, Thomas Först, Eberhard Draeger, Lars Endahl, Birgitte Rønn, Michael A. Nauck and Agnès Hincelin-Méry and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Christoph Kapitza

76 papers receiving 3.0k citations

Peers

Countries citing papers authored by Christoph Kapitza

Since Specialization

Citations

This map shows the geographic impact of Christoph Kapitza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Kapitza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Kapitza more than expected).

Fields of papers citing papers by Christoph Kapitza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Kapitza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Kapitza. The network helps show where Christoph Kapitza may publish in the future.

Co-authorship network of co-authors of Christoph Kapitza

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Kapitza. A scholar is included among the top collaborators of Christoph Kapitza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Kapitza. Christoph Kapitza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist BI 456906 2022 ·Diabetes Obesity and Metabolism ·Arvid Jungnik, Jorge Arrubla, Leona Plum‐Mörschel, Christoph Kapitza, Daniela Lamers, Claus Thamer, Corinna Schölch, Michael Desch, Anita M. Hennige	48
2	Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study 2020 ·Diabetes Obesity and Metabolism ·Tim Heise, Helle Linnebjerg, David E. Coutant, Elizabeth LaBell, Eric Zijlstra, Christoph Kapitza, Juliana Bue‐Valleskey, Qianyi Zhang, Mary Anne Dellva, Jennifer Leohr	47
3	Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 Diabetes 2019 ·Diabetes Technology & Therapeutics ·Christoph Kapitza, Leszek Nosek, (unknown), Lenore Teichert, Irene Nowotny	15
4	Impact of Injection Speed, Volume, and Site on Pain Sensation 2017 ·Journal of Diabetes Science and Technology ·Eric Zijlstra, (unknown), Annelie Fischer, Christoph Kapitza, Thomas Först	56
5	Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial 2017 ·Diabetologia ·Christoph Kapitza, Kirsten Dahl, Jacob Jacobsen, Mads Axelsen, Anne Flint	81
6	Microvascular effects of the inhibition of dipeptidylpeptidase IV by linagliptin in nondiabetic hypertensive patients 2015 ·Journal of Hypertension ·Thomas Först, Georg Michelson, (unknown), (unknown), Christoph Kapitza	10
7	Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear 2015 ·Drug Delivery and Translational Research ·(unknown), (unknown), Diane Sutter, (unknown), (unknown), Leszek Nosek, Christoph Kapitza, Kerstin Rebrin, Laurence Hirsch, Ronald J. Pettis	31
8	Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin 2013 ·Diabetes Obesity and Metabolism ·Christoph Kapitza, Thomas Först, (unknown), Franck Poitiers, Peter Ruus, Agnès Hincelin-Méry	161
9	Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes 2012 ·Diabetes Research and Clinical Practice ·Michael Horowitz, Anne Flint, Karen L. Jones, Charlotte Hindsberger, Mads Frederik Rasmussen, Christoph Kapitza, Selena Doran, Thomas Jax, Milan Zdravković, Ian Chapman	144
10	The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients 2011 ·Advances in Therapy ·Anne Flint, Christoph Kapitza, Charlotte Hindsberger, Milan Zdravković	75
11	Safety and tolerability of high doses of taspoglutide, a once‐weekly human GLP‐1 analogue, in diabetic patients treated with metformin: a randomized double‐blind placebo‐controlled study^1,2 2010 ·Diabetic Medicine ·Robert E. Ratner, Michael A. Nauck, Christoph Kapitza, Veronica Asnaghi, Mark Boldrin, R. Balena	37
12	How pharmacokinetic and pharmacodynamic principles pave the way for optimal basal insulin therapy in type 2 diabetes 2010 ·International Journal of Clinical Practice ·Sabine Arnolds, B. Kuglin, Christoph Kapitza, Tim Heise	53
13	Piragliatin (RO4389620), a Novel Glucokinase Activator, Lowers Plasma Glucose Both in the Postabsorptive State and after a Glucose Challenge in Patients with Type 2 Diabetes Mellitus: A Mechanistic Study 2010 ·The Journal of Clinical Endocrinology & Metabolism ·Riccardo C. Bonadonna, Tim Heise, (unknown), Christoph Kapitza, Angelo Avogaro, (unknown), (unknown), Joseph F. Grippo, R. Balena	115
14	Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes 2010 ·Diabetes Care ·Christoph Kapitza, Eric Zijlstra, Lutz Heinemann, Mariacristina Castelli, (unknown), Tim Heise	49
15	Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once‐weekly, human GLP‐1 analogue, after single‐dose administration in patients with Type 2 diabetes 2009 ·Diabetic Medicine ·Christoph Kapitza, Tim Heise, P Birman, (unknown), Joaquim Ramis, R. Balena	29
16	Glucose monitoring by microdialysis: performance in a multicentre study 2009 ·Diabetic Medicine ·(unknown), Guido Freckmann, Christoph Kapitza, Gregor Ocvirk, (unknown), Ulrike Kamecke, (unknown), Ildikó Amann-Zalán, Nina Jendrike, J. S. Christiansen, Theodor Koschinsky, Lutz Heinemann	15
17	Changes in Basal Insulin Infusion Rates With Subcutaneous Insulin Infusion 2009 ·Diabetes Care ·Lutz Heinemann, Leszek Nosek, Christoph Kapitza, (unknown), Lars Krinelke	41
18	Dependency of the Metabolic Effect of sc-Injected Human Regular Insulin on Intra-abdominal Fat in Patients with Type 2 Diabetes 2004 ·Hormone and Metabolic Research ·Klaus Rave, Leszek Nosek, Lutz Heinemann, Annke Frick, R. H. A. Becker, Christoph Kapitza	4
19	Intrasubject Variability of Inhaled Insulin in Type 1 Diabetes: A Comparison with Subcutaneous Insulin 2004 ·Diabetes Technology & Therapeutics ·Christoph Kapitza, Marcus Hompesch, B. SCHARLING, Tim Heise	20
20	How rapid does blood glucose concentration change in daily-life of patients with Type 1 diabetes? 2002 ·Diabetologia ·Karsten Jungheim, Christoph Kapitza, (unknown), (unknown), T Koschinsky, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact